Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Music for Psilocybin Therapy and the Temporal Arc of Psychedelic ExperienceResearch Square · 2026-08-03Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone FormulationClinicalTrials.gov · 2026-07-07Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-03Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-28Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)ClinicalTrials.gov · 2026-05-14157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium DynamicsBiological Psychiatry · 2026-04-25Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot StudyClinicalTrials.gov · 2026-02-05Acute psilocin increased cortical activity in ratFrontiers in Neuroscience · 2026-02-04Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-18Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-12The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in PsilocybebioRxiv · 2026-01-02Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-19Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.BJPsych open · 2025-12-15Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic CancerClinicalTrials.gov · 2025-11-05Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are requiredDrugs & Therapy Perspectives · 2025-11-04The emotional architecture of the psychedelic brain.Trends in cognitive sciences · 2025-11-01Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.Journal of medicinal chemistry · 2025-10-23Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant EffectsFigshare · 2025-10-15Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-29Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on AlcoholismClinicalTrials.gov · 2025-09-24PRoMiSS: Psilocybin and the Role of Music in Set and SettingClinicalTrials.gov · 2025-09-18Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-13Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.Healthcare (Basel, Switzerland) · 2025-09-12Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2025-09-08Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation RetreatmedRxiv · 2025-07-30Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy AdultsClinicalTrials.gov · 2025-06-10Psilocybin With Intracranial Neural SensingClinicalTrials.gov · 2025-06-06Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.Nature · 2025-06-01[Treatment with psychedelics: potential benefits in Parkinson's disease].Revue medicale suisse · 2025-04-23The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice.Pharmaceuticals (Basel, Switzerland) · 2025-03-23Elucidating the Phase I metabolism of psilocin in vitroArchives of Toxicology · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTSThe international journal of neuropsychopharmacology · 2025-02-01Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-21Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.Palliative medicine reports · 2025-01-01A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.PloS one · 2025-01-01Additions to the sect. (Agaricales) in China: new species from tropical rainforests, new geographical distributions, and toxin detection.Frontiers in microbiology · 2025-01-01Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Therapeutic advances in psychopharmacology · 2025-01-01Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire.Frontiers in psychology · 2025-01-01Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.Journal of chemical information and modeling · 2024-10-14Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.Journal of psychopharmacology (Oxford, England) · 2024-10-01What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study.Palliative & supportive care · 2024-10-01WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Scientific reports · 2024-04-23Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Scientific reports · 2024-03-26Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliative medicine · 2024-02-01Psilocybin and eugenol prevent DSS-induced neuroinflammation in miceBiocatalysis and Agricultural Biotechnology · 2024-01-25Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2024-01-01The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.Frontiers in psychiatry · 2024-01-01Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01Cultivation, chemistry, and genome of.bioRxiv: the preprint server for biology · 2023-11-02Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Neuroscience and biobehavioral reviews · 2023-11-01A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-27A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issuesPsyArXiv · 2023-10-27Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.Pharmacological research · 2023-08-01Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.Neurosurgery · 2023-04-01The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.Molecules (Basel, Switzerland) · 2023-03-14Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use DisorderClinicalTrials.gov · 2023-01-17Visualizing drug actions on dendrites: psilocybin and other classic psychedelicsBiophotonics Congress: Optics in the Life Sciences 2023 (OMA, NTM, BODA, OMP, BRAIN) · 2023-01-01Acute psilocybin increased cortical activities in rats.Frontiers in neuroscience · 2023-01-01Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.Frontiers in psychiatry · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.Fungal biology · 2022-04-01Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-19Structure-based discovery of nonhallucinogenic psychedelic analogs.Science (New York, N.Y.) · 2022-01-28Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01Multi-locus identification of by high-resolution melting (HRM).Forensic sciences research · 2022-01-01Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?Bioengineered · 2021-12-01Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.Fa yi xue za zhi · 2021-10-25Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.Neuron · 2021-08-18A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.Cell reports · 2021-07-20The Role of Psychedelics and Counseling in Mental Health TreatmentJournal of Mental Health Counseling · 2020-10-01Qualitative analysis of synthetic opioids, synthetic hallucinogens and LSD in urine using LC-MS/MSAustralian Journal of Forensic Sciences · 2019-02-11Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brainNeuropharmacology · 2015-12-01Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.Addictive behaviors · 2004-06-01Wasson's alternative candidates for soma.Journal of psychoactive drugs · 1993-01-01Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.Molecular pharmacology · 1973-01-01"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.American Journal of Psychiatry · 1964-01-30